Chemometric and Transcriptomic Profiling, Microtubule Disruption and Cell Death Induction by Secalonic Acid in Tumor Cells.

作者: Nadire Özenver , Mona Dawood , Edmond Fleischer , Anette Klinger , Thomas Efferth

DOI: 10.3390/MOLECULES25143224

关键词:

摘要: Nature is an indispensable source of new drugs, providing unique bioactive lead structures for drug discovery. In the present study, secalonic acid F (SAF), a naturally occurring ergochrome pigment, was studied its cytotoxicity against various leukemia and multiple myeloma cells by resazurin assay. SAF exhibited cytotoxic activity on both cells. Generally, were more sensitive to than NCI-H929 most affected among tested panel cell lines taken further studies assess mode action those Cell cycle analysis revealed that induced S G2/M arrest in SAF-associated apoptosis necrosis resulted cytotoxicity. inclined disassembly tubulin network, which may also account COMPARE hierarchical cluster analyses transcriptome-wide expression profiles NCI tumor line identified genes involved numerous cellular processes (e.g., differentiation, migration, other signaling pathways) notably correlated with log10IC50 values acid. conclusion, study supports therapeutic potential treat myeloma.

参考文章(54)
D.J. Aberhart, Y.S. Chen, P. de Mayo, J.B. Stothers, Mould metabolites—IV Tetrahedron. ,vol. 21, pp. 1417- 1432 ,(1965) , 10.1016/S0040-4020(01)98303-6
Santosh Kumar Guru, Anup Singh Pathania, Suresh Kumar, Deshidi Ramesh, Manjeet Kumar, Satiander Rana, Ajay Kumar, Fayaz Malik, P.R. Sharma, B.K. Chandan, Sundeep Jaglan, J.P. Sharma, Bhahwal Ali Shah, Sheikh Abdullah Tasduq, Surrinder K. Lattoo, Abdul Faruk, A.K. Saxena, R.A. Vishwakarma, Shashi Bhushan, Secalonic Acid-D Represses HIF1α/VEGF-Mediated Angiogenesis by Regulating the Akt/mTOR/p70S6K Signaling Cascade Cancer Research. ,vol. 75, pp. 2886- 2896 ,(2015) , 10.1158/0008-5472.CAN-14-2312
Elias Jabbour, Susan O'Brien, Marina Konopleva, Hagop Kantarjian, New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia Cancer. ,vol. 121, pp. 2517- 2528 ,(2015) , 10.1002/CNCR.29383
Ya-peng Hu, Li-yang Tao, Fang Wang, Jian-ye Zhang, Yong-ju Liang, Li-wu Fu, Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2 Biochemical Pharmacology. ,vol. 85, pp. 1619- 1625 ,(2013) , 10.1016/J.BCP.2013.04.003
Mary Ann Jordan, Leslie Wilson, Microtubules as a target for anticancer drugs. Nature Reviews Cancer. ,vol. 4, pp. 253- 265 ,(2004) , 10.1038/NRC1317
Zhigang She, Changlun Shao, Lu Wen, Fan Liu, Zhonghui Zheng, Yongcheng Lin, Zhiyong Guo, H-1 and C-13 NMR signal assignments of Paecilin A and B, two new chromone derivatives from mangrove endophytic fungus Paecilomyces sp (tree 1-7) Magnetic Resonance in Chemistry. ,vol. 45, pp. 777- 780 ,(2007) , 10.1002/MRC.2035
Jian-ye Zhang, Li-yang Tao, Yong-ju Liang, Yan-yan Yan, Chun-ling Dai, Xue-kui Xia, Zhi-gang She, Yong-cheng Lin, Li-wu Fu, Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway Cell Cycle. ,vol. 8, pp. 2444- 2450 ,(2009) , 10.4161/CC.8.15.9170
Irina Kaverina, Anne Straube, Regulation of cell migration by dynamic microtubules Seminars in Cell & Developmental Biology. ,vol. 22, pp. 968- 974 ,(2011) , 10.1016/J.SEMCDB.2011.09.017
Douglas T Ross, Uwe Scherf, Michael B Eisen, Charles M Perou, Christian Rees, Paul Spellman, Vishwanath Iyer, Stefanie S Jeffrey, Matt Van de Rijn, Mark Waltham, Alexander Pergamenschikov, JC Lee, Deval Lashkari, Dari Shalon, Timothy G Myers, John N Weinstein, David Botstein, Patrick O Brown, None, Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics. ,vol. 24, pp. 227- 235 ,(2000) , 10.1038/73432
L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. Simon, S. Tosini, P. Skehan, D. A. Scudiero, A. Monks, M. R. Boyd, Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Journal of the National Cancer Institute. ,vol. 82, pp. 1113- 1118 ,(1990) , 10.1093/JNCI/82.13.1113